ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,936.70
      -0.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Graphite Bio Inc (GRPH)

      7. Graphite Bio Inc (GRPH) News

      GRPH

      Graphite Bio (GRPH)

      Graphite Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GRPH
      DateTimeSourceHeadlineSymbolCompany
      07/21/20224:41PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GRPHGraphite Bio Inc
      07/15/202212:51PMTipRanksMorgan Stanley Sticks to Their Hold Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
      07/13/20224:32PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GRPHGraphite Bio Inc
      06/23/20224:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/22/20225:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      06/01/20228:00AMBusiness WireGraphite Bio Announces Participation in Jefferies Healthcare ConferenceNASDAQ:GRPHGraphite Bio Inc
      05/19/20228:42AMTipRanksSVB Securities Thinks Graphite Bio’s Stock is Going to RecoverNASDAQ:GRPHGraphite Bio Inc
      05/16/20226:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      05/16/20226:00AMBusiness WireGraphite Bio Presents Preclinical Gene Replacement Data for GPH102 for Beta-thalassemia at the ASGCT 25th Annual MeetingNASDAQ:GRPHGraphite Bio Inc
      05/12/20224:15PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRPHGraphite Bio Inc
      05/12/20224:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      05/12/20224:05PMBusiness WireGraphite Bio Reports Recent Business Progress and First Quarter 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      05/04/20228:00AMBusiness WireGraphite Bio Announces Participation in Upcoming Investor ConferencesNASDAQ:GRPHGraphite Bio Inc
      05/03/20228:50AMDow Jones NewsGraphite Bio Gets Fast Track Designation for GPH101 Sickle Cell TreatmentNASDAQ:GRPHGraphite Bio Inc
      05/03/20228:00AMBusiness WireGraphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
      05/02/20224:38PMBusiness WireGraphite Bio Announces Participation in the ASGCT 25th Annual Meeting Including Oral Presentation About Beta-thalassemia ProgramNASDAQ:GRPHGraphite Bio Inc
      04/29/20224:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GRPHGraphite Bio Inc
      04/29/20224:05PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GRPHGraphite Bio Inc
      04/13/20227:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      04/13/20227:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      04/05/20226:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRPHGraphite Bio Inc
      04/05/20225:58PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GRPHGraphite Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GRPH